Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia von Aitken, Marisa J. L, Ravandi, Farhad, Patel, Keyur P, Short, Nicholas J

Volltext

Emerging treatment options for patients with p53-pathway-deficient CLL von Aitken, Marisa J. L., Lee, Hun J., Post, Sean M.

Volltext

Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas von Gallardo, Miguel, Malaney, Prerna, Aitken, Marisa J L, Zhang, Xiaorui, Link, Todd M, Shah, Vrutant, Alybayev, Sanzhar, Wu, Meng-Han, Pageon, Laura R, Ma, Huaxian, Jacamo, Rodrigo, Yu, Li, Xu-Monette, Zijun Y, Steinman, Haley, Lee, Hun Ju, Sarbassov, Dos, Rapado, Inmaculada, Barton, Michelle C, Martinez-Lopez, Joaquin, Bueso-Ramos, Carlos, Young, Ken H, Post, Sean M

Volltext

The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies von Malaney, Prerna, Velasco-Estevez, María, Aguilar-Garrido, Pedro, Aitken, Marisa J L, Chan, Lauren E, Zhang, Xiaorui, Post, Sean M, Gallardo, Miguel

Volltext

Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy von Kannan, Sankaranarayan, Irwin, Mary E, Herbrich, Shelley M, Cheng, Tiewei, Patterson, LaNisha L, Aitken, Marisa J L, Bhalla, Kapil, You, M James, Konopleva, Marina, Zweidler-McKay, Patrick A, Chandra, Joya

Volltext

Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML von Herbrich, Shelley, Baran, Natalia, Cai, Tianyu, Weng, Connie, Aitken, Marisa J L, Post, Sean M, Henderson, Jared, Shi, Chunhua, Havranek, Ondrej, Richard-Carpentier, Guillame, Sauvageau, Guy, Baggerly, Keith, Al-Atrash, Gheath, Davis, R Eric, Daver, Naval, Zha, Dongxing, Konopleva, Marina

Volltext

Thirty‐three years later: Two distinct cases of acute lymphoblastic leukemia in one patient von Aitken, Marisa J.L., Benton, Christopher B., Wang, Feng, Zhang, Jianhua, Herbrich, Shelley M., Takahashi, Koichi, Bueso‐Ramos, Carlos E., Short, Nicholas J.

Volltext

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3 -ITD acute myeloid leukemia von Post, Sean M, Ma, Huaxian, Malaney, Prerna, Zhang, Xiaorui, Aitken, Marisa J L, Mak, Po Yee, Ruvolo, Vivian R, Yasuhiro, Tomoko, Kozaki, Ryohei, Chan, Lauren E, Ostermann, Lauren B, Konopleva, Marina, Carter, Bing Z, DiNardo, Courtney, Andreeff, Michael D, Khoury, Joseph D, Ruvolo, Peter P

Volltext

Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer von Aitken, Marisa J.L., Benton, Christopher B., Issa, Ghayas C., Sasaki, Koji, Yilmaz, Musa, Short, Nicholas J.

Volltext

Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia von Kannan, Sankaranarayanan, Aitken, Marisa J L, Herbrich, Shelley M, Golfman, Leonard S, Hall, Mandy G, Mak, Duncan H, Burks, Jared K, Song, Guangchun, Konopleva, Marina, Mullighan, Charles G, Chandra, Joya, Zweidler-McKay, Patrick A

Volltext

Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing von Aitken, Marisa J L, Malaney, Prerna, Zhang, Xiaorui, Herbrich, Shelley M, Chan, Lauren, Benitez, Oscar, Rodriguez, Ashley G, Ma, Huaxian, Jacamo, Rodrigo, Duan, Ruizhi, Link, Todd M, Kornblau, Steven M, Kanagal-Shamanna, Rashmi, Bueso-Ramos, Carlos E, Post, Sean M

Volltext

Anti-Leukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia von Kannan, Sankaranarayanan, Aitken, Marisa J. L., Herbrich, Shelley M., Golfman, Leonard S., Hall, Mandy G., Mak, Duncan H, Burks, Jared K, Song, Guangchun, Konopleva, Marina, Mullighan, Charles G., Chandra, Joya, Zweidler-McKay, Patrick A.

Volltext

Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer von Aitken, Marisa J L, Benton, Christopher B, Issa, Ghayas C, Sasaki, Koji, Yilmaz, Musa, Short, Nicholas J

Volltext